CD34-indexT | |||
---|---|---|---|
Above median (>), n (%) | Below median (≤), n (%) | p-value | |
Total | 12 | 13 | |
Age (years) | 0.543 | ||
> Median (57.2) | 5 (41.7) | 7 (58.3) | |
≤ Median (57.2) | 7 (53.8) | 6 (46.2) | |
Sex | 0.225 | ||
Male | 10 (55.6) | 8 (44.4) | |
Female | 2 (28.6) | 5 (71.4) | |
Treatment group | 0.848 | ||
IL2/ IFN-α | 6 (46.2) | 7 (53.8) | |
IL2/INF-α/bevacizumab | 6 (50.0) | 6 (50.0) | |
IMDC category | 0.152 | ||
Favourable | 2 (100.0) | - | |
Intermediate | 9 (50.0) | 9 (50.0) | |
Poor | 1 (20.0) | 4 (80.0) | |
Target lesion volume (cm3) | 0.848 | ||
> Median (44.9) | 6 (46.2) | 7 (53.8) | |
≤ Median (44.9) | 6 (50.0) | 6 (50.0) | |
Synchronous metastases | 0.378 | ||
Yes | 8 (42.1) | 11 (57.9) | |
No | 4 (66.7) | 2 (33.3) |